Masterclass: Year-to-Date Review: A Rollercoaster Year for DTx

DTx has faced numerous challenges in the past year. 

As we have navigated through these murky waters, it’s clear that the viability of DTx in 2024 depends on innovative approaches that address widespread issues of adoption and integration and a shift away from solely relying on regulatory clearance as a strategy for success. 

DTx must find its place within the intricate web of payer acceptance, clinical adoption, and seamless integration into existing healthcare systems. Only by recognising and addressing these interconnected factors can we truly unlock the full potential of DTx and change the way we approach healthcare in the foreseeable future. 

Join this meeting to collaboratively shape the next phase of DTx:

• How can DTx companies succeed financially in a challenging economic environment?

• What can be done to improve the quality of evidence for DTx and make it more appealing to payers? 

• How can we increase HCP adoption of DTx, considering integration challenges and resistance to change?